行情

ATRC

ATRC

AtriCure
NASDAQ

实时行情|Nasdaq Last Sale

32.90
+0.52
+1.59%
交易中 11:23 04/02 EDT
开盘
31.99
昨收
32.38
最高
33.05
最低
31.64
成交量
3.64万
成交额
--
52周最高
44.51
52周最低
22.57
市值
13.17亿
市盈率(TTM)
-35.3292
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ATRC价格均价为48.83,最高价位52.00,最低价为42.00。

EPS

ATRC 新闻

更多
  • Dayton stocks dive again after Q1 registers biggest drop since 2008
  • American City Business Journals · 19小时前
  • These Dayton stocks skyrocketed as market posts best day since 1933
  • American City Business Journals · 03/24 22:09
  • Here's how Dayton stocks fared as Dow falls to lowest level since 2016
  • American City Business Journals · 03/23 19:29
  • Dayton stocks tumble as Dow falls, ending 11-year bull run
  • American City Business Journals · 03/12 14:21

所属板块

医疗设备、用品及经销
+2.22%
医疗设备和用品
+2.52%

热门股票

代码
价格
涨跌幅

ATRC 简况

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).
展开

微牛提供AtriCure Inc.(NASDAQ-ATRC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ATRC股票新闻,以帮助您做出投资决策。